Aim To conduct a systematic review and meta‐analysis to determine the risk of
cardiovascular events and all‐cause mortality associated with sulphonylureas (SUs) vs …

This study was based on a survey of graduate students in the Educational Leadership &
Counseling Department at Texas A&M University-Kingsville. The study first determined to …

Abstract Management of type 2 diabetes mellitus (T2DM) is complex and challenging,
particularly for clinicians working in primary care who are faced with many competing clinical …

Considerable evidence supports the hypothesis that estrogen prevents bone loss by
blocking the bone marrow cell production of pro‐osteoclastogenic cytokines. However …

OBJECTIVE It is known that continuous glucose monitoring (CGM) systems can lower mean
glucose compared with episodic self-monitoring of blood glucose. Implantable CGM systems …

Institutions of higher learning have struggled to retain incoming freshmen, especially
Hispanic students, who historically face greater challenges to succeed. The purpose of this …

Introduction Insulin degludec (degludec) is a basal insulin with an ultra-long, stable action
profile and reduced pharmacodynamic variability. Seven phase 3a trials compared …

People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney
disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor …

We formed the GEnetics of Nephropathy–an International Effort (GENIE) consortium to
examine previously reported genetic associations with diabetic nephropathy (DN) in type 1 …

Cardiovascular disease (CVD), including heart failure (HF), is a leading cause of morbidity
and mortality in people with type 2 diabetes mellitus (T2DM). CVD and T2DM share common …